Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 36-40 , April 2007

Spironolactone is not Effective for the Treatment of Hypokalemia in Peritoneal Dialysis Patients

References 

  1. Spital A , Sterns RH . Potassium supplementation via the dialysate in continuous ambulatory peritoneal dialysis . Am J Kidney Dis . 1985;6:173–176
  2. Oreopoulos DG , Khanna R , Williams P , Vas SI . Continuous ambulatory peritoneal dialysis – 1981 . Nephron . 1982;30:293–303
  3. Khan A , Bernardini J , Johnston J , Piraino B . Hypokalemia in peritoneal dialysis patients . Perit Dial Int . 1996;16:652
  4. Dolson GM . Do potassium deficient diets and K+ removal by dialysis contribute to the cardiovascular morbidity and mortality of patients with end-stage renal disease? . Int J Artif Organs . 1997;20:134–135
  5. Bargman J , Jamison R . Disorders of potassium homeostasis . In:  Sutton R ,  Dirks J editor. Diuretics: Physiology, Pharmacology and Clinical Use . Philadelphia: WB Saunders; 1986;p. 296–319
  6. Sandle GI , Gaiger E , Tapster S , Goodship TH . Evidence for large intestinal control of potassium homoeostasis in uremic patients undergoing long-term dialysis . Clin Sci (Lond) . 1987;73:247–252
  7. Allon M , Dansby L , Shanklin N . Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease . Am J Med . 1993;94:475–482
  8. Sandle GI , Gaiger E , Tapster S , Goodship TH . Enhanced rectal potassium secretion in chronic renal insufficiency: evidence for large intestinal potassium adaptation in man . Clin Sci (Lond) . 1986;71:393–401
  9. Gifford JD , Rutsky EA , Kirk KA , McDaniel HG . Control of serum potassium during fasting in patients with end-stage renal disease . Kidney Int . 1989;35:90–94
  10. Mathialahan T , Sandle GI . Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease . Nephrol Dial Transplant . 2003;18:341–347
  11. Sandle GI , McNicholas CM , Lomax RB . Potassium channels in colonic crypts . Lancet . 1994;343:23–25
  12. Turnamian SG , Binder HJ . Aldosterone and glucocorticoid receptor-specific agonists regulate ion transport in rat proximal colon . Am J Physiol Gastrointest Liver Physiol . 1990;258:G492–G498
  13. Schulman G , Miller-Diener A , Litwack G , Bastl CP . Characterization of the rat colonic aldosterone receptor and its activation process . J Biol Chem . 1986;261:12102–12108
  14. Van Olden RW , Krediet RT , Struijk DG , Arisz L . Measurement of residual renal function in patients treated with continuous peritoneal dialysis . J Am Soc Nephrol . 1996;7:745–750
  15. Szeto CC , Wong TY , Leung CB , Wang AY , Law MC , Lui SF , et al.   Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients . Kidney Int . 2000;58:400–407
  16. Szeto CC , Wong TY , Chow KM , Leung CB , Law MC , Li PK . Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients . Perit Dial Int . 2004;24:58–64
  17. Ritz E , McClellan WM . Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences . J Am Soc Nephrol . 2004;15:513–516
  18. Ritz E , Dikow R , Adamzcak M , Zeier M . Congestive heart failure due to systolic dysfunction: the Cinderella of cardiovascular management in dialysis patients . Semin Dial . 2002;15:135–140
  19. Goldsmith DJ , Covic A . Coronary artery disease in uremia: etiology, diagnosis, and therapy . Kidney Int . 2001;60:2059–2078
  20. Paul M , Pinto YM , Schunkert H , Ganten D , Bohm M . Activation of the renin-angiotensin system in heart failure and hypertrophy — studies in human hearts and transgenic rats . Eur Heart J . 1994;15(Suppl D):63–67
  21. Rodgers JE , Patterson JH . The role of the renin-angiotensinaldosterone system in the management of heart failure . Pharmacotherapy . 2000;20(11 Suppl):368S–378S
  22. Brilla CG , Rupp H , Funck R , Maisch B . The renin-angiotensinaldosterone system and myocardial collagen matrix remodelling in congestive heart failure . Eur Heart J . 1995;16(Suppl O):107–109
  23. MacFadyen RJ , Barr CS , Struthers AD . Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients . Cardiovasc Res . 1997;35:30–34
  24. Barr CS , Lang CC , Hanson J , Arnott M , Kennedy N , Struthers AD . Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease . Am J Cardiol . 1995;76:1259–1265
  25. Macfadyen RJ , Barr CS , Struthers AD . Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients . Cardiovasc Res . 1997;35:30–34
  26. Pitt B , Zannad F , Remme WJ , Cody R , Castaigne A , Perez A , et al.   The effect of spironolactone on morbidity and mortality in patients with severe heart failure . N Engl J Med . 1999;341:709–717
  27. Juurlink DN , Mamdani MM , Lee DS , Kopp A , Austin PC , Laupacis A , et al.   Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study . N Engl J Med . 2004;351:543–551
  28. Saudan P , Mach F , Perneger T , Schnetzler B , Stoermann C , Fumeaux Z , et al.   Safety of low-dose spironolactone administration in chronic haemodialysis patients . Nephrol Dial Transplant . 2003;18:2359–2363
  29. Hussain S , Dreyfus DE , Marcus RJ , Biederman RW , McGill RL . Is spironolactone safe for dialysis patients? . Nephrol Dial Transplant . 2003;18:2364–2368

PII: S1561-5413(07)60007-6

doi: 10.1016/S1561-5413(07)60007-6

Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 36-40 , April 2007

Article Tools